Target intelligence / Profile preview

MicroRNA 548ay (MIR548AY)

Target
MIR548AY
Molecular classification
microRNA (miRNA), Non-coding RNA, Regulatory RNA, Other: Not a receptor, enzyme, transporter, or transcription factor
01

Overview

MicroRNA 548ay is a primate-specific small non-coding RNA gene (miRNA) involved in post-transcriptional regulation of gene expression, acting primarily by binding to target mRNAs to either inhibit their translation or promote their degradation[3]. MIR548AY belongs to the large miR-548 gene family, which is notable for its poor sequence conservation, distribution across most human chromosomes, and evolutionary origin from transposable elements[1][2][3]. Members of the miR-548 family regulate a wide array of biological processes, including cell proliferation, inflammation, and potentially oncogenesis; however, the specific functions and disease associations of MIR548AY itself remain largely uncharacterized[3]. The mature miRNAs are produced through canonical Drosha/Dicer processing and act via the RNA-induced silencing complex (RISC) to control gene expression[3]. There is currently no evidence that MIR548AY itself serves as a direct therapeutic target, biomarker, or is modulated by any approved drugs.

Other names
hsa-mir-548ayhsa-miR-548aymicroRNA mir-548ayMIR548AY
02

Biological functions

Post-transcriptional regulation of gene expressionmRNA stability modulationTranslational inhibitionLikely involved in cell proliferation and inflammation (by association with other miR-548 members)Other: Potential involvement in hyperproliferative and inflammatory skin conditions (e.g., psoriasis, from family association)
03

Disease associations

Other: No direct disease links are established for MIR548AY; however, the miR-548 family is implicated in cancer, inflammation, and cell proliferation, particularly hyperproliferative and inflammatory phenotypes such as those seen in psoriasis lesions

Beyond the preview

Go deeper on MicroRNA 548ay (MIR548AY).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548ay (MIR548AY).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call